Posters

2019

2019

2019

Chuah, E.

AGBT

Platform for report generation and sharing of clinical genomics data.

2019

Csizmok, V.

ICGC ARGO

Personalized OncoGenomics (POG): whole genome and transcriptome sequencing informs treatments decisions in the cancer clinic.

2019

Dixon, K.

ACMG ANNUAL MEETING

Molecular pathogenesis of familial pancreatic cancer and implications for genetic diagnosis.

2019

Lee, M.

GI ASCO

Comprehensive genomic analysis of metastatic pancreatic adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable abberations.

2019

Mendis, S.

ASCO

Comprehensive transcriptome analysis reveals link between epigenetic dysregulation, endogenous retrovirus expression and immunogenicity in metastatic colorectal carcinoma.

2019

Moore, R.

AGBT

Integration of whole genome and transcriptome analysis informs personalized therapy decision making and highlights how cancer genomes are shaped by prior therapy.

2019

Nelson, J.

ICGC ARGO

Collaborative publication process in the Personalized OncoGenomics (POG) program.

2019

Pearson, H.

SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA ANNUAL CONFERENCE

Genomic and transcriptomic immune-tumour profilimg for predictive biomarkers of checkpoint inhibitor response in metastatic cancer.

2019

Roscoe, R.

ICGC ARGO

Management of a large-scale project in personalized medicine and cancer genomics.

2019

Roscoe, R.

ICGC ARGO

Management of a large-scale personalized medicine and cancer genomics program.

2019

Roscoe, R.

ICGC ARGO

Early-stage economic evaluation of whole-genome and transcriptome analysis to guide advanced cancer care.

2019

Roscoe, R.

ICGC ARGO

An introduction and illustrative example of matching methods in precision oncology.

2019

Thibodeau, M.L.

CCMG/CAGC

Characterization of germline structural variants in moderate-high penetrance hereditary cancer genes in the Personalized OncoGenomics cohort.

2019

Titmuss, E.

KEYSTONE SYMPOSIA CONFERENCE

Integrated genomic profiling of metastatic tumours to identify biomarkers of response to immune checkpoint inhibitors.

2019

Titmuss, E.

ICGC ARGO

Pan-cancer analysis of advanced patient tumours reveals interaction between therapy and genomic landscapes.

2019

Weinberg, B.A.

ESMO GI

NRG1 fusion-positive gastrointestinal tumours: Afatinib as a novel potential treatment option.

2019

Weymann, D.

ICGC ARGO

An introduction and illustrative example of matching methods in precision oncology.

2019

Weymann, D.

ICGC ARGO

Early-stage economic evaluation of whole-genome and transcriptome analysis to guide advanced cancer care.

2018

2018

Culibrk, L.

BC CANCER RESEARCH CENTRE RESEARCH DAY

TC-seqR: a statistical framework for estimation of tumour purity and ploidy from whole genome sequencing data.

2018

Culibrk, L.

GENOME BC RESEARCH DAY

TC-seqR: a statistical framework for estimation of tumour purity and ploidy from whole genome sequencing data.

2018

Culibrk, L.

BC CANCER SUMMIT

Ploidetect: interpreteable detection of tumour content and aneuploidy from whole genome sequence data.

2018

Culibrk, L.

BC CANCER SUMMIT

Ploidetect: interpretable detection of tumor content and aneuploidy from whole genome sequence data.

2018

Fan, K.

BC CANCER SUMMIT

Genomic analysis of tumour-immune landscape and determinants of response to immune checkpoint inhibitors in Personalized Oncogenomics patients.

2018

Kwan, H.

BC CANCER SUMMIT

Exploratory analysis of recurrent mutations associated with treatment in metastatic cancers.

2018

Lavoie, J.-M.

BC CANCER SUMMIT

Patient selection for a developmental therapeutics programs using multi-omics.

2018

LeVasseur, N.

ASCO

Whole genome sequencing in metastatic breast cancer: lessons learned from the BC Cancer Agency Personalized OncoGenomics (POG) program.

2018

Liu, L.

ESMO

Clinical benefit of whole genome and transcriptome analysis (WGTA) in metastatic colorectal cancer (MCRC): results from the Personalized OncoGenomics (POG) program.

2018

Liu, L.

BC CANCER SUMMIT

Clinical benefit of whole genome and transcriptome analysis (WGTA) in metastatic colorectal cancer (MCRC): results from the Personalized Oncogenomics program (POG).

2018

Pleasance, E.

BC CANCER SUMMIT

Cancer genome landscapes shaped by prior therapy: the POG500 cohort.

2018

Pleasance, E.

BC CANCER SUMMIT

Integration of whole genome and transcriptome analysis informs personalized therapy decision making and highlights how cancer genomes are shaped by prior therapy.

2017

2017

Bonakdar, M.

CCRC

Comprehensive bioinformatics analysis of whole genome and transcriptome sequence data from individual patient tumours.

2017

Bonakdar, M.

AGBT

Bioinformatics for Personalized OncoGenomics: analysis of whole genome and transcriptome data from individual patient tumours.

2017

Bonakdar, M.

PERSONALIZED MEDICINE SUMMIT

Comprehensive bioinformatics analysis of whole genome and transcriptome sequence data from individual patient tumours.

2017

Chooback, N.

CAMO

Whole genome sequencing (WGS) analysis of lung adenocarcinoma: elucidating the molecular signature.

2017

Jones, M.

AGBT PRECISION HEALTH

Taking whole genomes to the cancer clinic: integrative analysis for interpretation and communication of whole genome and transcriptome analysis at a tumour board.

2017

Karasinska, J.

KEYSTONE TUMOR METABOLISM MEETING

Prognostic metabolic signature associated with mutant KRAS copy gain in pancreatic ductal adenocarcinoma.

2017

Lim, H.

AACR-NCI-EORTC MOLECULAR TARGETS AND CANCER THERAPEUTICS CONFERENCE

Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.

2017

Lim, H.

ASCO

Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.

2017

Ma, Y.

AGBT

Bioinformatics for Personalized OncoGenomics: lessons learned from analyzing whole genomes and transcriptomes from 500 patients.

2017

Pearson, H.

4TH CANADIAN CANCER RESEARCH CONFERENCE

Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.

2017

Pearson, H.

CCRC

Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort.

2017

Pleasance, E.

CCRC

Personalized OncoGenomics: whole genome and transcriptome sequencing informs treatment decisions in the cancer clinic.

2017

Pleasance, E.

PERSONALIZED MEDICINE SUMMIT

Personalized OncoGenomics: whole genome and transcriptome sequencing informs treatment decisions in the cancer clinic.

2017

Roscoe, R.

SOCIETY OF RESEARCH ADMINISTRATORS INTERNATIONAL (SRAI)

Personalized OncoGenomics (POG) project: program management and process development.

2017

Shen, Y.

AACR-NCI-EORTC MOLECULAR TARGETS AND CANCER THERAPEUTICS

Clinical application of whole genome and transcriptome sequencing in cancer care.

2017

Thibodeau, M.

CCRC

Whole-genome and whole-transcriptome profiling of a metastatic eccrine porocarcinoma.

2017

Tsang, E.

ASCO

Clinical outcomes after whole genome sequencing in patients with metastatic non small cell lung cancer.

2017

Williamson, L.

CCRC

Genomic profiling of pancreatic ductal adenocarcinoma identifies DNA repair deficient subtype.

2017

Zhao, E.

AACR

Breast cancer whole genomes link homologous recombination deficiency (HRD) with therapeutic outcomes.

2016

2016

Grewal, J.

TFRI- NODE

Using machine learning to identify site of origin of metastatic tumours.

2016

Jones, M.

AGBT

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2016

Laskin, J.

AACR

Restrictions on access to systemic therapy limit the application of whole genome sequencing in clinical care.

2016

Moore, R.

AGBT

Whole genome and transcriptome sequencing for personalized cancer therapy: lessons learned from the first 300 cases.

2016

Schrader, I.

AACR

Genomic analysis of pancreatic ductal adenocarcinoma in a patient with MUTYH-associated polyposis.

2016

Zhao, E.

CITAC

Guiding platinum-based chemotherapy in breast cancer with a somatic mutation signature of homologous recombination deficiency.

2015

2015

Bose, P.

AACR PRECISION MEDICINE SERIES: INTEGRATING CLINICAL GENOMICS AND CANCER THERAPY

Integrated genomic analysis of a recurrent ghost cell odontogenic carcinoma.

2015

Fok, A.

CANADIAN GE3LS AND HEALTH SERVICES & POLICY RESEARCH CONFERENCE

Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.

2015

Jones, M.

PERSONALIZED MEDICINE SUMMIT

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2015

Koyama, T.

AMERICAN SOCIETY OF HUMAN GENETICS

Case analysis of advanced cancers with Watson Genomic Analytics.

2015

Lim, H.

ESMO

Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology.

2015

Ma, Y.

AGBT

A bioinformatics pipeline for analyzing whole genome and transcriptome sequence data from individual patient tumours.

2015

Moore, R.

AGBT

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2015

Rassekh, R.

ASPHO

Pediatric Personalized OncoGenomics (PedsPOG): initial outcomes.

2015

Roscoe, R.

PERSONALIZED MEDICINE SUMMIT

Management of a large -scale personalized medicine project.

2015

Sheffield, B.

USCAP

Personalized OncoGenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.

2015

Sun, S.

AACR

Personalized OncoGenomics in advanced stage breast cancer.

2015

Yip , S.

USCAP

Next generation pathology: the integration of next generation sequencing with glass-based histomorphology and immunohistochemistry.

2015

Zhao, E.

CLINICIAN INVESTIGATOR PROGRAM RESEARCH FELLOW DAY

Searching for targetable mutation signatures in a mixed cancer cohort.

2015

Zhao, E.

PERSONALIZED MEDICINE SUMMIT

Searching for targetable mutation signatures in a mixed cancer cohort.

2014

2014

Jones, M.

7TH ANNUAL RECOMB/ISCB CONFERENCE ON REGULATORY & SYSTEMS GENOMICS WITH DREAM CHALLENGES

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2014

Jones, M.

TFRI- NODE

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2014

Kasaian, K.

AACR

Bioinformatic analyses approaches for personalized oncogenomics.

2014

Kasaian, K.

GENOME BC SBN

Bioinformatic analyses approaches for personalized oncogenomics.

2014

Laskin, J.

AACR

Whole genome sequencing is superior to cancer panels to aid in decision-making in patients with advanced malignancies.

2014

Lim, H.

ESMO

Practical guidance for ethical and policy issues that arise from the clinical application of whole genome sequencing in cancer patients.

2014

Mungall, A.

3RD TCGA SYMPOSIUM

Using TCGA data to inform on precision medicine in late-stage cancer settings.

2014

Rassekh, R.

TFRI- NODE

Pediatric Personalized OncoGenomics (PedsPOG): initial outcomes.

2014

Zhao, E.

CLINICIAN INVESTIGATOR TRAINEE ASSOCIATION OF CANADA ANNUAL GENERAL MEETING

Networks, signatures, and personalized medicine: a whole genome approach to cancer therapy.

ABSTRACTS

2019

2019

2019

Culibrk, L.

INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY (ISMB) CONFERENCE

Ploidetect: interpretable detection of tumor content and aneuploidy from whole genome sequence data.

2019

Karasinska, J.

KEYSTONE TUMOR METABOLISM SYMPOSIUM

Metabolic gene expression heterogeneity is associated with survival in pancreatic cancer.

2019

Karasinska, J.

AACR - PANCREATIC CANCER: ADVANCES IN SCIENCE AND CLINICAL CARE

Gene expression along the glycolysis-cholesterol synthesis axis and outcome in pancreatic cancer.

2019

LeVasseur, N.

ASCO

Whole transcriptome sequencing in metastatic cancer: a review of expression outliers in 113 metastatic breast cases.

2019

Lee, M.

GI ASCO

Comprehensive genomic analysis of metastatic pancreatic ductal adenocarcinoma (mPDAC) reveals a significant proportion of clinical actionable aberrations.

2019

Liu, L.

SOCIETY OF GYNECOLOGIC ONCOLOGY

Outcomes of whole genome and transcriptome sequencing (WGTS) in advanced gynecologic malignancies: results from the Personalized Oncogenomics (POG) program.

2019

Mendis, S.

ASCO

Comprehensive transcriptome analysis reveals link between epigenetic dysregulation, endogenous retrovirus expression and immunogenicity in metastatic colorectal carcinoma.

2019

Pender, A.

ESMO

Predictive markers of checkpoint inhibitor activity in adult metastatic solid tumours.

2019

Shen, Y.

BC CANCER SUMMIT

Application of integrated analysis of whole genome sequencing and RNA sequencing to personalized therapy decision making in pediatric cancer.

2019

Tsang, E.

ASCO

Uncovering clinically relevant gene fusion events with integrated genomic and transcriptomic profiling.

2019

Williamson, L.

AGBT PRECISION HEALTH MEETING

Cancer genome landscapes shaped by prior therapy: the POG570 cohort.

2019

Zhao, E.

ASCO

The whole genome landscape of adult metastatic sarcoma.

2018

2018

Culibrk, L.

ASHG

Ploidetect: interpretable detection of tumour content and aneuploidy from whole genome sequence data.

2018

Lavoie, J.-M.

CELL SYMPOSIA: MULTI-OMIC STUDIES IN CANCER

Patient selection for a developmental therapeutics program using whole genome and transcriptome analysis.

2018

Liu, L.

ASCO

Clinical utility of whole genome sequencing (WGS) in metastatic colorectal cancer (MCRC): results from the Personalized OncoGenomics (POG) program.

2018

Moore, R.

AGBT

Utilization of whole genome analysis approaches for personalized therapy decision making in patients with advanced malignancies.

2018

Murchison, S.

CARO

Establishing a role for tumor genomics in radiation medicine: an analysis of head and neck cancer patients enrolled in the Personalized OncoGenomics (POG) initiative.

2018

Thibodeau, M.L.

ASCO

Genomic profiling and mutational signatures associated with the germline deletion polymorphism APOBEC3A_B in diverse cancer types.

2018

Williamson, L.

AACR

Integrated whole genome profiling of the immune tumour interaction identifies predictive biomarkers of checkpoint inhibitor response in metastatic cancer.

2018

Williamson, L.

CARO-COMP-CAMRT

Establishing a role for tumour genomics in radiation medicine: an analysis of primary head and neck cancer data obtained from the Personalized OncoGenomics (POG) initiative.

2017

2017

Tsang, E.

ASCO

Clinical outcomes after whole genome sequencing in patients with metastatic non small cell lung cancer.

2017

Yang, KC.

B.I.G. RESEARCH DAY AT UBC

Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing.

2017

Yang, KC.

MBB GRADUATE COLLOQUIUM

Molecular characterization of pancreatic neuroendocrine tumours using whole genome and transcriptome sequencing.

2016

2016

Ho, C.

ESMO

The incorporation of tumor whole genome sequencing in practice: the impact on clinical decision-making and therapeutic choices.

2016

Koyama, T.

ASCO

Watson Genomic Analytics efficiently interprets whole genome sequencing data from cancer patients with advanced disease at high throughput.

2016

Laskin, J.

ESMO

Clinicians identify high need to increase their genomic literacy to applied cancer genomics.

2016

Lever, J.

BIOCREATIVE CONFERENCE

CancerMine: a knowledgebase of cancer drivers for personalized cancer treatment.

Back to top